Summary

As President Trump heads to Beijing to stabilize fragile trade relations, domestic tensions are peaking over a massive $1.5 trillion defense budget and the sudden resignation of FDA Commissioner Dr. Marty Makary. These events signal a tightening grip on both international leverage and federal regulatory control.

Key Topics

• Rare Earth Leverage: Rare earths are critical for tech and defense manufacturing. China's dominance in the supply chain forces the U.S. to tread carefully in trade negotiations, as the U.S. cannot easily replace these materials. This dynamic has shifted the power balance at the negotiating table.
• Regulatory Capture: In this context, the FDA's leadership changes demonstrate political actors forcing policy outcomes that conflict with institutional processes. This undermines public trust and creates a cycle of instability.

Key Takeaways

• Monitor the upcoming Senate confirmation hearings for the next permanent FDA Commissioner.